{"disease":{"id":"rectosigmoid-junction-cancer","name":"rectosigmoid junction cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05566249","title":"A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT03328065","title":"Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours","phase":"","overall_status":"TERMINATED","enrollment_count":36,"lead_sponsor_name":"Centre Hospitalier Universitaire Dijon","has_results":false},{"nct_id":"NCT05943041","title":"Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"GILongevity","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}